Hepta Medical

Hepta Medical is a private, pre-revenue medical device company focused on enhancing the precision of microwave ablation, a minimally invasive tumor treatment. Its core innovation is a platform combining a real-time, in-situ temperature sensor with predictive software to monitor and control the ablation zone dynamically. This technology addresses a key limitation in current ablation procedures—the lack of real-time feedback on treatment efficacy—potentially leading to more predictable outcomes and reduced complications. The company appears to be in the development and prototyping stage, targeting a significant opportunity in the interventional oncology market.

Integrated microwave ablation platform featuring a patented in-situ tissue temperature sensor combined with proprietary predictive software for real-time monitoring and control of the ablation zone.

Hepta competes in the tumor ablation device market dominated by large players like Medtronic, Boston Scientific, and Johnson & Johnson. Its differentiation is the direct, real-time temperature feedback and predictive control, a feature not commonly available in existing systems, though competitors are also investing in navigation and visualization software enhancements.